Journal of immunological methods
PLGA-based nanovaccine delivering chimeric IpaD-StxB protein induces robust immune response against Shigella infection.
Ayoub Fazeli, Hosein Honari, Davoud Sadeghi, Hossein Samiei-Abianeh, Rasoul Rafiei-Foroushani
Published: 202610.1016/j.jim.2026.114036
Abstract
BACKGROUND AND AIM: Shigellosis is a major cause of morbidity and mortality worldwide, especially among children under five in low- and middle-income countries. Despite its public health burden, there is no licensed vaccine. Recombinant and nanoparti…
Preview only. Read the full abstract at the source